UNIGE document Scientific Article
previous document  unige:54948  next document
add to browser collection

Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice

da Silva, Rafaela F
Fraga-Silva, Rodrigo A
Capettini, Luciano
Quintao, Silvia
show hidden authors show all authors [1 - 19]
Published in Journal of cerebral blood flow and metabolism. 2013, vol. 33, no. 4, p. 490-498
Abstract Neutrophilic inflammation might have a pathophysiological role in both carotid plaque rupture and ischemic stroke injury. Here, we investigated the potential benefits of the CXC chemokine-binding protein Evasin-3, which potently inhibits chemokine bioactivity and related neutrophilic inflammation in two mouse models of carotid atherosclerosis and ischemic stroke, respectively. In the first model, the chronic treatment with Evasin-3 as compared with Vehicle (phosphate-buffered saline (PBS)) was investigated in apolipoprotein E-deficient mice implanted of a 'cast' carotid device. In the second model, acute Evasin-3 treatment (5 minutes after cerebral ischemia onset) was assessed in mice subjected to transient left middle cerebral artery occlusion. Although CXCL1 and CXCL2 were upregulated in both atherosclerotic plaques and infarcted brain, only CXCL1 was detectable in serum. In carotid atherosclerosis, treatment with Evasin-3 was associated with reduction in intraplaque neutrophil and matrix metalloproteinase-9 content and weak increase in collagen as compared with Vehicle. In ischemic stroke, treatment with Evasin-3 was associated with reduction in ischemic brain neutrophil infiltration and protective oxidants. No other effects in clinical and histological outcomes were observed. We concluded that Evasin-3 treatment was associated with reduction in neutrophilic inflammation in both mouse models. However, Evasin-3 administration after cerebral ischemia onset failed to improve poststroke outcomes.
Keywords AnimalsAtherosclerosis/blood/complications/drug therapyBrain Infarction/blood/etiology/pathology/prevention & controlBrain Injuries/blood/etiology/pathology/prevention & controlCarotid Artery Diseases/blood/complications/drug therapy/pathologyChemokine CXCL1/bloodMiceMice, KnockoutNeutrophil Infiltration/drug effectsNeutrophils/metabolism/pathologyReceptors, CXCRStroke/blood/etiology/pathology/prevention & control
PMID: 23250107
Full text
Article (Published version) (610 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Groupe Gasche Yvan (Soins intensifs) (501)
Groupe Schaller Karl Lothard (neurochirurgie) (851)
L'athérosclérose et ses complications cliniques (591)
(ISO format)
COPIN, Jean-Christophe et al. Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice. In: Journal of cerebral blood flow and metabolism, 2013, vol. 33, n° 4, p. 490-498. doi: 10.1038/jcbfm.2012.198 https://archive-ouverte.unige.ch/unige:54948

514 hits

0 download


Deposited on : 2015-03-31

Export document
Format :
Citation style :